Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Engel

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
International Journal of Physiology, Pathophysiology and Pharmacology|January 31, 2019
Profiling of Argonaute-2-loaded microRNAs in a mouse model of frontotemporal dementia with parkinsonism-17Aidan Kenny, Félix Hernández, Jesús Avila, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 15, 2016
A calcium-sensitive feed-forward loop regulating the expression of the ATP-gated purinergic P2X7 receptor via specificity protein 1 and microRNA-22Tobias Engel, Gary P Brennan, Amaya Sanz-Rodriguez, et al.
Cell Death & Disease|January 13, 2017
Deletion of the BH3-only protein Noxa alters electrographic seizures but does not protect against hippocampal damage after status epilepticus in miceNaoki Ichikawa, Mariana Alves, Shona Pfeiffer, et al.
Neuroscience Letters|January 23, 2009
Effects of transient focal cerebral ischemia in mice deficient in pumaKatsura Kuroki, Isabelle Virard, Caoimhin G Concannon, et al.
Journal of Medical Economics|February 4, 2021
Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspectiveTobias Engel Ayer Botrel, Márcia Datz Abadi, Laura Chabrol Haas, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 16, 2011
Ideal vial size for bortezomib: real-world data on waste and cost reduction in treatment of multiple myeloma in BrazilLuciana Clark, Ana Paula Castro, Anna Flávia Fortes, et al.
Core Evidence|March 26, 2013
Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysisTobias Engel Ayer Botrel, Otávio Clark, Antônio Carlos Lima Pompeo, et al.
Plos One|June 17, 2016
Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-AnalysisTobias Engel Ayer Botrel, Otávio Clark, Antônio Carlos Lima Pompeo, et al.
Cells|September 28, 2021
Circulating P2X7 Receptor Signaling Components as Diagnostic Biomarkers for Temporal Lobe EpilepsyGiorgia Conte, Aida Menéndez-Méndez, Sebastian Bauer, et al.
CNS Neuroscience & Therapeutics|April 23, 2014
P2X7 receptor inhibition interrupts the progression of seizures in immature rats and reduces hippocampal damageGuillaume Mesuret, Tobias Engel, Ellen V Hessel, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
International Journal of Physiology, Pathophysiology and Pharmacology|January 31, 2019
Profiling of Argonaute-2-loaded microRNAs in a mouse model of frontotemporal dementia with parkinsonism-17Aidan Kenny, Félix Hernández, Jesús Avila, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 15, 2016
A calcium-sensitive feed-forward loop regulating the expression of the ATP-gated purinergic P2X7 receptor via specificity protein 1 and microRNA-22Tobias Engel, Gary P Brennan, Amaya Sanz-Rodriguez, et al.
Cell Death & Disease|January 13, 2017
Deletion of the BH3-only protein Noxa alters electrographic seizures but does not protect against hippocampal damage after status epilepticus in miceNaoki Ichikawa, Mariana Alves, Shona Pfeiffer, et al.
Neuroscience Letters|January 23, 2009
Effects of transient focal cerebral ischemia in mice deficient in pumaKatsura Kuroki, Isabelle Virard, Caoimhin G Concannon, et al.
Journal of Medical Economics|February 4, 2021
Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspectiveTobias Engel Ayer Botrel, Márcia Datz Abadi, Laura Chabrol Haas, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 16, 2011
Ideal vial size for bortezomib: real-world data on waste and cost reduction in treatment of multiple myeloma in BrazilLuciana Clark, Ana Paula Castro, Anna Flávia Fortes, et al.
Core Evidence|March 26, 2013
Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysisTobias Engel Ayer Botrel, Otávio Clark, Antônio Carlos Lima Pompeo, et al.
Plos One|June 17, 2016
Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-AnalysisTobias Engel Ayer Botrel, Otávio Clark, Antônio Carlos Lima Pompeo, et al.
Cells|September 28, 2021
Circulating P2X7 Receptor Signaling Components as Diagnostic Biomarkers for Temporal Lobe EpilepsyGiorgia Conte, Aida Menéndez-Méndez, Sebastian Bauer, et al.
CNS Neuroscience & Therapeutics|April 23, 2014
P2X7 receptor inhibition interrupts the progression of seizures in immature rats and reduces hippocampal damageGuillaume Mesuret, Tobias Engel, Ellen V Hessel, et al.
Pageof 15